Completed
WT1 Vaccine Treatment of Patients With Multiple Myeloma After Autologous Stem Cell Transplantation
NCT01827137
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +27 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States